LATE-BREAKING ABSTRACT: Effect of fluticasone furoate (FF)/vilanterol (VI) on the rate of COPD exacerbations in everyday clinical practice: Results of the COPD Salford lung study (SLS)

被引:0
|
作者
Vestbo, Jorgen
Leather, David
New, John P.
Bakerly, Nawar Diar
Crawford, Jodie
Collier, Sue
Gibson, Martin
McCorkindale, Sheila
Harvey, Catherine
Yates, Louisa
Woodcock, Ashley
机构
关键词
COPD; -; management; Exacerbation; Primary care;
D O I
10.1183/13993003.congress-2016.OA249
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
OA249
引用
收藏
页数:2
相关论文
共 46 条
  • [1] Clinical Effectiveness Of Fluticasone Furoate/vilanterol (ff/vi): The Impact On Exacerbations In COPD Patient Subgroups Of The Salford Lung Study (sls COPD)
    Bakerly, N.
    Woodcock, A. A.
    Collier, S.
    Leather, D. A.
    New, J. P.
    Crawford, J.
    Vestbo, J.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [2] The Clinical Effectiveness Of Fluticasone Furoate/vilanterol (ff/vi) In Everyday Clinical Practice: Patient Reported Outcomes In The Salford Lung Study (sls COPD)
    Woodcock, A. A.
    Boucot, I.
    Browning, D.
    Collier, S.
    Sedgley, J.
    Millar, J.
    Lay-Flurrie, J.
    McCorkindale, S.
    Vestbo, J.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [3] IDENTIFICATION OF RESPONDER GROUPS TO FLUTICASONE FUROATE/VILANTEROL (FF/VI) IN THE SALFORD LUNG STUDY IN COPD (SLS COPD) USING A CLUSTER ANALYSIS MODEL
    Nicholls, A.
    Bakerly, N. Diar
    Collier, S.
    Dickinson, H.
    Leather, D.
    Boucot, I.
    [J]. THORAX, 2017, 72 : A230 - +
  • [4] Late Breaking Abstract - Effectiveness of Fluticasone furoate/vilanterol (FF/VI) compared to usual care (UC) in patients with asthma: The Salford Lung Study (SLS)
    Leather, David
    Vestbo, Jorgen
    Bakerly, Nawar Diar
    Fletcher, Joanne L.
    New, John P.
    Gibson, J. Martin
    Mccorkindale, Sheila
    Collier, Sue
    Lay-Flurrie, James
    Frith, Lucy
    Jacques, Loretta
    Harvey, Catherine
    Svedsater, Henrik
    Woodcock, Ashley
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [5] Effect Of Fluticasone Furoate (ff)/vilanterol (vi) Compared With Vi On COPD Exacerbations: A Pre-Specified Subgroup Analysis
    Dransfield, M. T.
    Calverley, P. M.
    Bourbeau, J.
    Jones, P. W.
    Hanania, N. A.
    Mahler, D. A.
    Vestbo, J.
    Wachtel, A.
    Martinez, F. J.
    Barnhart, F.
    Midwinter, D.
    Lettis, S.
    Crim, C.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [6] Effects of Fluticasone Furoate/Vilanterol (FF/VI) on Patient-Reported Outcomes: The Salford Lung Study in Asthma (SLS Asthma)
    Svedsater, H.
    Bosanquet, N.
    Jacques, L.
    Jones, R.
    Lay-Flurrie, J.
    Leather, D. A.
    Vestbo, J.
    Woodcock, A.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [7] The Salford Lung Asthma Study - Summary of a randomized controlled Trial for Comparison of the Efficacy of Fluticasone Furoate / Vilanterol (FF/VI) with the Standard Therapy in Everyday Clinical Practice
    Stegherr, Anna-Maria
    Zoelch, Bernadette
    Mohrlang, Cordula
    [J]. INTERNIST, 2018, 59 : S45 - S45
  • [8] Effect Of Fluticasone Furoate (ff)/vilanterol (vi) On Lung Function In COPD: A Pre-Specified Subgroup Analysis
    Martinez, F. J.
    Midwinter, D. A.
    Lettis, S.
    Scott-Wilson, C.
    Crim, C.
    Kerwin, E. M.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [9] Cost Implications of Fluticasone Furoate/Vilanterol (FF/VI) Versus Usual Care (UC): Results from the Salford Lung Study (SLS) in Asthma Applied in a US Context
    Svedsater, H.
    van de Wetering, G.
    Ignacio, T.
    Driessen, M. T.
    Browning, D.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [10] Effect of fluticasone furoate (FF)/vilanterol (VI) compared with VI on acute exacerbations of COPD (AECOPD): A post-hoc analysis by baseline airflow obstruction
    Leather, David
    Yates, Louisa
    Newlands, Amy
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2015, 46